DRUG NAME: Azacitidine
Hematologic toxicity (i.e., anemia, neutropenia, leukopenia, and thrombocytopenia) is associated with azacitidine therapy, particularly during the first two cycles and less frequently thereafter.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Oncology Nutrition High Protein High Energy …
www.bccancer.bc.caHigh Protein High Energy Food Choices 3 Examples of High Protein Foods • All meat (eg. beef, pork, goat, lamb) • Fish and shellfish • All poultry (eg. chicken, turkey, duck)
High, Food, Energy, Nutrition, Oncology, Protein, Oncology nutrition high protein high energy, Protein foods
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:
Safe Handling of Hazardous Drugs - BC Cancer
www.bccancer.bc.caA.1 Potential Hazards of Handling Hazardous Drugs..... 1 A.2 Hazardous Drug List.....
“Magic” mouthwash explained - BC Cancer
www.bccancer.bc.caFAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,
Symptom Management Guidelines: ORAL …
www.bccancer.bc.caSymptom Management Guidelines: ORAL MUCOSITIS . Definition Oral Mucositis (Stomatitis): An acute inflammation and/or ulceration of the …
Guidelines, Management, Symptom, Oral, Symptom management guidelines, Oral mucositis, Mucositis
Guidelines for Management of CID - BC Cancer
www.bccancer.bc.caDisclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide
British Columbia Cancer Agency POLICY
www.bccancer.bc.caBritish Columbia Cancer Agency ¦ POLICY Title: PREVENTION AND MANAGEMENT OF EXTRAVASATION OF CHEMOTHERAPY Number: III-20 Effective Date: Provincial Systemic Program September 1,1997
Policy, Management, Prevention, Agency, Columbia, British, Cancer, British columbia cancer agency policy, British columbia cancer agency, 166 policy
Symptom Management Guidelines: FEVER AND …
www.bccancer.bc.caSymptom Management Guidelines: FEVER AND NEUTROPENIA . Definition • Fever: A single oral temperature of ≥ 38.3° C (101° F) OR a temperature ≥ 38 ° C (100.4 ° F) which lasts more than 1h
Guidelines, Management, Fever, Symptom, Oral, Symptom management guidelines, Fever and, Fever and neutropenia, Neutropenia
Symptom Management Guidelines: XEROSTOMIA
www.bccancer.bc.caSymptom Management Guidelines: XEROSTOMIA. Definition(s) • Xerostomia: abnormal dryness in the mouth characterized by a marked decrease and/or thickening of saliva, may be
Guidelines, Management, Symptom, Symptom management guidelines, Xerostomia
Linking the BC Psychosocial Community Oncology …
www.bccancer.bc.caCarolyn Jacob - New Regional Professional Practice Leader at the Centre for the North. We welcome Carolyn Jacob, MSW, RSW to her new role at the BC
Psychosocial, Community, Linking, Oncology, Linking the bc psychosocial community oncology
Related documents
Content Blueprint for the Physician Assistant National ...
prodcmsstoragesa.blob.core.windows.netHematologic System 5% Infectious Diseases 6% Musculoskeletal System 8% ... Sepsis/systemic inflammatory response syndrome Spirochetal diseases • Lyme disease ... • Fibrocystic changes • Galactorrhea • Gynecomastia • Mastitis Cervical disorders
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.cimzia.comdeath including tuberculosis (TB), bacterial sepsis, invasive fungal infections (such as histoplasmosis), and infections due to other opportunistic pathogens (5.1). o CIMZIA should be discontinued if a patient develops a serious infection or sepsis (5.1). o Perform test for latent TB; if positive, start treatment for TB prior to starting CIMZIA ...
COVID-19 (Acute COVID and MIS-C) Care
www.seattlechildrens.orgsepsis, or multi-organ failure • Tier 1 and 2 labs • Consider Sepsis Pathway • ED Guidance: Resuscitation for High-Risk COVID Patient • EKG, CXR, consider ECHO • Consult PICU and Infectious Disease • Consult Rheumatology for hyperinflammation • Imaging for thrombi as indicated by clinical evaluation as D-dimer expected to be ...
Evaluation of Patients with Leukocytosis
www.aafp.orgDec 01, 2015 · The normal range for WBC counts changes with age and pregnancy (Table 1).3 Healthy newborn infants may have a WBC count from 13,000 to 38,000 per mm3 (13.0 to 38.0 × 109 per L) at 12 hours of ...
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …
www.pfizer.caPatients with severe infections such as sepsis, abscesses, tuberculosis and opportunistic infections (see WARNINGS AND PRECAUTIONS, Risk of Infections). Patients with moderate or severe (NYHA Class III/IV) congestive heart failure (see WARNINGS AND PRECAUTIONS, Cardiovascular and ADVERSE REACTIONS, Congestive Heart Failure).